Weber Shandwick brings on veteran PR hand Smirnoff

Share this article:
Susan Smirnoff
Susan Smirnoff

PR Firm Weber Shandwick announced that Susan Smirnoff will join its health practice as EVP/senior counselor.

Smirnoff joins Weber from another New York-based shop, Ruder Finn, where she co-led its US healthcare practice in addition to working as a senior counselor on the healthcare and corporate communications teams. She also serves as president of the board of trustees for CancerCare, a cancer patient support network.

Smirnoff brings with her extensive experience in oncology and neuroscience. Laura Schoen, president of Weber Shandwick's healthcare practice said in a release: “Susan's passion for science and her commitment to delivering programs that impact patient outcomes is a perfect match to our culture.”

That commitment will be tested as news came in July that the US Department of Health and Human Services (HHS) added $33 million to the agency's contract, in an effort to further awareness of state health insurance exchanges, reported PRWeek. Earlier this year, Weber also won a contract from Covered California—the organization running the state's health insurance exchange. The $12 million contract includes creative development, social media and collateral materials through April 2015.

Smirnoff's experience also encompasses “disease awareness, life-cycle brand programs, promoting business alliance, supporting clinical trial recruitment and addressing the communications challenges of Rx-to-OTC switches,” the agency stated in the release.

In May, Weber added a specialty shop to its offerings: Element Scientific Communications.
Share this article:
close

Next Article in Agency Gallery

Email Newsletters

More in Agency Gallery

Private View: Creating Compelling Experiences

Private View: Creating Compelling Experiences

In today's multi-channel environment, game-changing ideas blend creativity and sensory ideation to create a meaningful customer experience

Putting consumers at the center of your universe

Putting consumers at the center of your universe

The question should be: How do you simplify and identify the moments that mean the most to customers?

Did "pay-to-play" confab help Zohydro approval?

Did "pay-to-play" confab help Zohydro approval?

US senators Joe Manchin (D-WV) and David Vitter (R-LA) are asking whether a "pay-to-play" meeting between drug industry executives and FDA officials influenced the agency's approval of Zohydro